Clinical Trials Browser

OTHER_GOV × Head and Neck Neoplasms × pembrolizumab × Clear all

NCT05551767 2022-09-23

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms

NCT05025813 2022-08-01

DESQUAMATE

Phase 2 Recruiting

Head and Neck Neoplasms